Regeneron Pharmaceuticals (REGN) Research & Development (2009 - 2026)
Regeneron Pharmaceuticals (REGN) reported Research & Development of $1.63 billion for Q2 2026, up 14.8% from $1.42 billion a year earlier and up 5.7% from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) Research & Development (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Regeneron Pharmaceuticals' Research & Development came in at $6.28 billion, up 15.5% year-over-year; for FY2025, it was $5.85 billion, up 14.0% from FY2024.
- Research & Development has increased for seven consecutive years, with a five-year compound annual growth rate of 17.2% (FY2020 to FY2025).
- By year, Research & Development came in at $5.13 billion in FY2024 (+15.6%), $4.44 billion in FY2023 (+23.6%), $3.59 billion in FY2022 (+25.6%) and $2.86 billion in FY2021 (+8.1%).
- The Q2 2026 figure ranks as the highest quarterly Research & Development in data going back to Q2 2009.
- Year over year, Research & Development has now increased in each of the last 19 quarters, with growth averaging 15.7% over the last eight quarters.
- The high point for year-over-year Research & Development in five years was Q4 2022 (growth of 41.4%); the low point was Q3 2021 (a decline of 2.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.54 billion (Q1 2026), $1.63 billion (Q4 2025) and $1.48 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Regeneron Pharmaceuticals | 81.27 Bn | 47.47 Bn | 3.71 Bn | 1.63 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.63 Bn |
| Mar 31, 2026 | 1.54 Bn |
| Dec 31, 2025 | 1.63 Bn |
| Sep 30, 2025 | 1.48 Bn |
| Jun 30, 2025 | 1.42 Bn |
| Mar 31, 2025 | 1.33 Bn |
| Dec 31, 2024 | 1.41 Bn |
| Sep 30, 2024 | 1.27 Bn |
| Jun 30, 2024 | 1.20 Bn |
| Mar 31, 2024 | 1.25 Bn |
| Dec 31, 2023 | 1.18 Bn |
| Sep 30, 2023 | 1.08 Bn |
| Jun 30, 2023 | 1.09 Bn |
| Mar 31, 2023 | 1.10 Bn |
| Dec 31, 2022 | 1.04 Bn |
| Sep 30, 2022 | 911.30 Mn |
| Jun 30, 2022 | 794.30 Mn |
| Mar 31, 2022 | 843.80 Mn |
| Dec 31, 2021 | 737.60 Mn |
| Sep 30, 2021 | 665.40 Mn |
API Access
Regeneron Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();